Trial of TopicalC-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial
A Randomized, Double-Blind, Placebo-Controlled Trial of TopicalC-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial A Randomized, Double-Blind, Placebo-Controlled Trial of TopicalC-82in Systemic Sclerosis - A Phase ...